BNP PARIBAS FINANCIAL MARKETS - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$271,318,000
+108.8%
2,062
-19.8%
0.00%
Q3 2020$129,963,000
+550.7%
2,572
+513.8%
0.00%
Q2 2020$19,974,000
-88.3%
419
-88.0%
0.00%
Q1 2020$171,024,000
+125.6%
3,491
+164.3%
0.00%
Q4 2019$75,812,000
+7.8%
1,321
-32.4%
0.00%
Q3 2019$70,321,000
+22.9%
1,955
+6.2%
0.00%
Q2 2019$57,218,000
-28.4%
1,841
-46.0%
0.00%
Q1 2019$79,964,0003,4100.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders